Holder snapshot 7 signals
Share change
+18,535,503
Put/Call ratio
98%
SEC-reported price per share
$1.58
Indexed holders
77
Value change
+$30,563,845
Number of buys
31
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,571,428,571

Security key

00653A107

Report period

Q1 2024

Indexed institutions

77

Top holders

10

Ownership snapshot

Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $30,906,529 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP has the largest disclosed position value at $30.91M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value Top 5
Matrix Capital Management Company... $30.91M
NEA Management Company, LLC $13.54M
BAILLIE GIFFORD & CO $12.62M
Long Focus Capital Management, LLC $9.58M
BAKER BROS. ADVISORS LP $8.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$30,906,529
38,974,185 shares
— 31 Dec 2023
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$13,544,624
17,079,778 shares
— 31 Dec 2023
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$12,618,327
15,912,140 shares
— 31 Dec 2023
Long Focus Capital Management, LLC
13F
Company
13F
—
denominator unverified
$9,584,924
12,086,915 shares
— 31 Dec 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$8,698,641
10,969,282 shares
— 31 Dec 2023
PFM Health Sciences, LP
13F
Company
13F
—
denominator unverified
$8,265,546
10,423,135 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
77
Shares
162,072,769
Indexed holders
77
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
76
Q1 2024 indexed holders
77
Indexed holder difference
1
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .